• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Chemical Methodologies
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 3 (2019)
Issue Issue 3, pp. 276-391
Issue Issue 2. pp. 145-275
Issue Issue 1. pp. 1-144
Volume Volume 2 (2018)
Volume Volume 1 (2017)
Figueroa-Valverde, L., Francisco, D., Marcela, R., Virginia, M., Elizabeth, M., Maria, L., Elodia, G., Eduardo, P., Lenin, H., Alondra, A., Jhair, C. (2019). Design and Synthesis of a Diaza-bicyclo-naphthalen-oxiranyl-methanone Derivative. Theoretical Analysis of Their Interaction with Cytochrome P450-17A1. Chemical Methodologies, 3(Issue 2. pp. 145-275), 194-210. doi: 10.22034/chemm.2018.147492.1083
Lauro Figueroa-Valverde; Diaz Cedillo Francisco; Rosas-Nexticapa Marcela; Mateu-Armand Virginia; Montano-Tapia Elizabeth; Lopez-Ramos Maria; García-Cervera Elodia; Pool Gómez Eduardo; Hau-Heredia Lenin; Alfonso-Jimenez Alondra; Cabrera-Tuz Jhair. "Design and Synthesis of a Diaza-bicyclo-naphthalen-oxiranyl-methanone Derivative. Theoretical Analysis of Their Interaction with Cytochrome P450-17A1". Chemical Methodologies, 3, Issue 2. pp. 145-275, 2019, 194-210. doi: 10.22034/chemm.2018.147492.1083
Figueroa-Valverde, L., Francisco, D., Marcela, R., Virginia, M., Elizabeth, M., Maria, L., Elodia, G., Eduardo, P., Lenin, H., Alondra, A., Jhair, C. (2019). 'Design and Synthesis of a Diaza-bicyclo-naphthalen-oxiranyl-methanone Derivative. Theoretical Analysis of Their Interaction with Cytochrome P450-17A1', Chemical Methodologies, 3(Issue 2. pp. 145-275), pp. 194-210. doi: 10.22034/chemm.2018.147492.1083
Figueroa-Valverde, L., Francisco, D., Marcela, R., Virginia, M., Elizabeth, M., Maria, L., Elodia, G., Eduardo, P., Lenin, H., Alondra, A., Jhair, C. Design and Synthesis of a Diaza-bicyclo-naphthalen-oxiranyl-methanone Derivative. Theoretical Analysis of Their Interaction with Cytochrome P450-17A1. Chemical Methodologies, 2019; 3(Issue 2. pp. 145-275): 194-210. doi: 10.22034/chemm.2018.147492.1083

Design and Synthesis of a Diaza-bicyclo-naphthalen-oxiranyl-methanone Derivative. Theoretical Analysis of Their Interaction with Cytochrome P450-17A1

Article 4, Volume 3, Issue 2. pp. 145-275, March and April 2019, Page 194-210  XML PDF (1.15 MB)
Document Type: Original Article
DOI: 10.22034/chemm.2018.147492.1083
Authors
Lauro Figueroa-Valverde email orcid 1; Diaz Cedillo Francisco2; Rosas-Nexticapa Marcela3; Mateu-Armand Virginia3; Montano-Tapia Elizabeth3; Lopez-Ramos Maria1; García-Cervera Elodia1; Pool Gómez Eduardo1; Hau-Heredia Lenin1; Alfonso-Jimenez Alondra1; Cabrera-Tuz Jhair1
1Laboratory of Pharmaco-Chemistry at the Faculty of Chemical Biological Sciences of the University Autonomous of Campeche, Av. Agustín Melgar s/n, Col Buenavista C.P.24039 Campeche Cam., México
2Escuela Nacional de Ciencias Biológicas del Instituto Politécnico Nacional. Prol. Carpio y Plan de Ayala s/n Col. Santo Tomas, México, D.F. C.P. 11340
3Facultad de Nutrición, Universidad Veracruzana. Médicos y Odontólogos s/n, 91010, Xalapa, Veracruz. México
Receive Date: 04 September 2018,  Revise Date: 22 September 2018,  Accept Date: 25 October 2018 
Abstract
Several agents have been used for the treatment of prostate cancer such as flutamide, galeterone, abiraterone and others; however, some of these drugs can produce some secondary effects. The aim of this study was to synthesize a diaza-bicyclo-naphthalen-oxiranyl-methanone derivative using some chemical tools. The structure of all compounds involved in this study was confirmed by spectroscopy and spectrometry data. In addition, the theoretical interaction of diaza-bicyclo-naphthalen-oxiranyl-methanone derivative with the cytochrome P450-17A1 enzyme (3RUK) was evaluated in a docking model using some drugs such as galeterone and abiraterone as controls. The results showed that diaza-bicyclo-naphthalen-oxiranyl-methanone could interact with different types of amino acid residues involving 3RUK protein surface as compared to both galeterone and abiraterone. This phenomenon may be due to the differences in the chemical structure of compounds. All these data indicate that diaza-bicyclo-naphthalen-oxiranyl-methanone derivative could change the biological activity of cytochrome P450-17A1 enzyme which may be translated as good candidates for prostate cancer.

Graphical Abstract

Design and Synthesis of a Diaza-bicyclo-naphthalen-oxiranyl-methanone Derivative. Theoretical Analysis of Their Interaction with Cytochrome P450-17A1
Keywords
Diaza-bicyclo-naphthalen-oxiranyl-methanone; Derivative; Prostate cancer; Cytochrome P450 17A1; Docking
Main Subjects
Applied Chemistry
References
[1] Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J. Cancer Res., 2005, 65:10946

[2] Ortelli L, Spitale A., Mazzucchelli L., Bordoni A. BMC Cancer, 2018, 18:733

[3] Rezaeifar Z., Rounaghi G.H., Es'haghi Z., Chamsaz M. Mater. Sci. Eng. C, 2018, 91:10

[4] Rachner T., Tsourdi E., Hofbauer L., N. Engl. J. Med., 2018, 378:2541

[5] Beebe J., Ruterbusch J., Bylsma L., Gillezeau C. Adv. Ther., 2018, 1:14

[6] Bono J.S., Logothetis C.J., Molina A., Fizazi K., North S., Chu L., Chi K.N., Jones R.J., Goodman O.B., Saad F., Staffurth J.N., Mainwaring P., Harland S., Flaig T.W., Hutson T.E., Cheng T., Patterson H., Hainsworth J.D., Ryan C.J., Sternberg C.N., EllardS.L., Fléhon A., Saleh M., Scholz M., Efstathiou E., Zivi A., Bianchini D., Loriot Y., Chieffo N., Kheoh T., Haqq C.M., Scher H.I. N. Engl. J. Med, 2011, 364:1995

[7] Saltzstein D., Shore N., Moul J., Chu F., Concepcion R., Motte S. Ther. Adv. Urol., 2017, 10:43

[8] Meani D., Solarić M., Visapää H., Rosén R., Janknegt R., Soče M. Ther. Adv. Urol., 2017 10:51

[9] Handratta V.D., Vasaitis T.S., Njar V.C.O., Gediya L.K., Kataria R., Chopra P., Newman D., Farquhar R., Guo Z., Qiu Y., Brodie A.M.H. J. Med. Chem., 2005, 48:2972

[10] Fehl C., Vogt C.D., Yadav R., Li K., Scott E.E., Aubé J.  J. Med. Chem., 2018, 61:4946

[11] Adsule S., Barve V., Chen D., Ahmed F., Dou Q.P., Padhye S., Sakar F.H. J. Med. Chem., 2006, 49:7242

[12] Njar V.C.O., Kato K., Nnane I.P., Grigoryev D.N., Long B.J., Brodie A.M.H. J. Med. Chem., 1998, 41:902

[13] Purushottamachar P., Godbole A.M., Gediya L.K., Martin M.S., Vasaitis T.S., Kwegyir-Afful A.K., Ramalingam S., Ates-Alagoz Z., Njar V.C.O. J. Med. Chem., 2013, 56:4880

[14] Figueroa-Valverde L., Díaz-Cedillo F., Rosas-Nexticapa M., García-Cervera E., Pool-Gómez E., López-Ramos M., Hau-Heredia L., Sarabia-Alcocer B. Monats. FürChem., 2010, 141:373

[15] Schnackenberg L.K., Beger R.D. J. Chem. Inf. Mod., 2005, 45:360

[16] Fisher R., Guhathakurta M. Astroph. J. Lett., 1995, 447:139

[17] Kuzikov A.V., Dugin N.O., Stulov S.V., Shcherbinin D.S., Zharkova M.S., Tkachev Y.V., Timofeev V.P., Veselovsky A.V., Shumyantseva V.V., Misharin A.Y. Steroids, 2014, 88:66

[18] Macindoe G., Mavridis L., Venkatraman V., Devignes M.D., Ritchie D.W. Nucleic acids Res., 2010, 38: W445

[19] Ramírez E., López, J., Chacón, P. Bioinformatics, 2016, 32:2386

[20] Kumar Y., Kuila B., Mahajan D., Singh P., Mohapatra M., Bhargava G. Tetraedron Lett, 2014, 55:2793

[21] Mann F.G., Mukherjee D.P. J. Chem. Soc., 1949, 1:2298

[22] Angelovski G., Eilbracht P., Tetrahedron, 2003, 59:8265

[23] Curtis P., Bunnelle H., Pagano G., Gopalakrishnan M., Faghi R.Syn. Com, 2006, 36:321

[24] Hiegel G.A., Hogenauer T.J., Lewis J.C. Synthet. Communicat., 2005, 35:2099

[25] Katritzky A., Majumder S., Jain R. Arkivo, 2003, 2003:74

[26] Sibi J., Jacob G., Orient J. Chem., 2013, 29:565

[27] Harte A.J., Gunnlaugsson T. Tetraedron Lett., 2006, 47:6321

[28] Katke S., Amrutkar S., Bhor R., Khairnar M. Int. J. Pharm. Sci. Res., 2011, 2:148

[29]   Borredon E., Clavellinas F., Delmas M., Gaset A., Sinisterra J.V. J. Org. Chem., 1990, 55:501

[30] Machida S., Isoda Y., Kunieda M., Tamiaki H. Tetraedron Lett., 2012, 53:6277

[31] Rawal V.H., Newton R.C., Krishnamurthy V. J. Org. Chem., 1990, 55:5181

[32] Xie M., Wang Z., Zhao Y. J. Polym. Sci., 2001, 39:2799

[33] Bhat B.A., Dhar K.L., Puri S.C., Saxena A.K., Shanmugavel M., Qazi G.N. Bioorg. Med. Chem. Lett., 2005, 15:3177

[34] Park K.K., Surh Y.J., Stewart B.C., Miller J.A. Biochem. Biophys. Res. Comm., 1990, 169:1094

[35] Figueroa-Valverde L., Díaz-Cedillo F., Rosas-Nexticapa M., Maldonado-Velazquez G., García-Cervera E., Pool-Gomez E., Jarquin-Barberena H., Lopez-Ramos M., Rodriguez-Hurtado F., Chan-Salvador M. Lett. Org. Chem., 2015, 12:394

[36] Schaus S.E., Brandes B.D., Larrow J.F., Tokunaga M., Hansen K.B., Gould A.E., Furrow M.E., Jacobsen E.N. J. Am. Chem. Soc., 2002, 124:1307

[37] Martinez L.E., Leighton J.L., Carsten D.H., Jacobsen E.N. J. Am. Chem. Soc., 1995, 117:5897

[38] Cumming H., Rücker C. ACS Omega, 2017, 2:6244

[39] Figueroa-Valverde L., Diaz-Cedillo F., Ramos M. Cervera E. Med. Chem. Res., 2011, 20:847

[40] Figueroa-Valverde L., Rosas-Nexticapa M., Mateu-Armand V., Herrera-Meza S., Lopez-Ramos M. Bioinerfase Res. Appl. Chem., 2018, 8:3161

[41] Mohr P., Taylor, B., Newell, D. J. Phys. Chem. Reference Data. 2008, 80: 633.

[42] Andersson C.D., Thysell E., Lindström A., Bylesjö M., Raubacher F., Linusson A. J. Chem. Inf. Model, 2007, 47:1673

[43] Elokely K.M., Doerksen R.J. J. Chem. Inf. Model, 2013, 53:1934

[44] Mandell J.G., Roberts V.A., Pique M.E., Kotlovyi V., Mitchell J.C. Protein Eng., 2001, 14:105

 

Statistics
Article View: 153
PDF Download: 117
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by sinaweb.